High throughput sars-COV-2 neutralizing antibody immunoassay for qualifying variants and testing of human serum samples.
Active Definitive Contract Awarded Last action
- Contract number
- 75A50122C00008
- Awardee
-
Monogram Biosciences, Inc. UEI LFM3XDVK31M7
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- -$15,612,612
Award facts
- Contract value 0% obligated
- $38,008,678.50 Current and potential, with all options
- Completion date 63% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | -$15,612,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | -$342 | |
| Other Administrative Action | -$270 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Definitize Letter Contract | $33,254,145 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $20,367,145 |
Show all 12
About this award
On November 29, 2021, the Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $38.0 million firm fixed-price definitive contract to Monogram Biosciences, Inc. for the development and delivery of a high-throughput SARS-CoV-2 neutralizing antibody immunoassay capable of qualifying variants and testing human serum samples. The contract, which extends through September 30, 2029, is being performed at Monogram's laboratory facility in South San Francisco, California. As a subsidiary of Laboratory Corporation of America Holdings, Monogram Biosciences was selected to establish critical diagnostic testing capabilities to support the federal government's pandemic response and public health preparedness efforts.
This award was not set aside for any socioeconomic category and represents part of a broader commitment by ASPR to develop and validate immunoassay testing platforms for COVID-19. The contract specifically funds the establishment of neutralizing antibody testing infrastructure, evaluation of vaccine and therapeutic candidates against emerging viral variants, and comprehensive analysis of human serum samples to detect neutralizing antibodies. Monogram Biosciences' award reflects its established expertise in high-throughput immunoassay testing services and positions the company to provide essential diagnostic capabilities for monitoring population-level immunity and supporting the evaluation of medical countermeasures throughout the contract period.
Quick answers
Who was awarded contract 75A50122C00008?
75A50122C00008 was awarded to Monogram Biosciences, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on November 29, 2021.
How much is contract 75A50122C00008 worth?
The government has obligated -$15,612,612 on 75A50122C00008. Its current value, with exercised options, is $38,008,679.
Was contract 75A50122C00008 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award